(Q45220355)

11 December 2017

title

Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats (English)

1 reference

11 December 2017

0 references

Quy N Diep

1

1 reference

11 December 2017

Farhad Amiri

2

1 reference

11 December 2017

Karim Benkirane

3

1 reference

11 December 2017

Pierre Paradis

4

1 reference

11 December 2017

Ernesto L Schiffrin

5

1 reference

11 December 2017

publication date

1 November 2004

1 reference

Canadian Journal of Physiology and Pharmacology

11 December 2017

published in

1 reference

11 December 2017

volume

82

1 reference

11 December 2017

issue

11

1 reference

11 December 2017

page(s)

976-985

1 reference

Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia

11 December 2017

cites work

1 reference

Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo

21 January 2018

1 reference

Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth

21 January 2018

1 reference

Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction

21 January 2018

1 reference

Expression of cell cycle proteins in blood vessels of angiotensin II-infused rats: role of AT(1) receptors

21 January 2018

1 reference

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group.

21 January 2018

1 reference

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

PPARgamma and atherosclerosis: effects on cell growth and movement

21 January 2018

1 reference

Signaling pathways for cardiac hypertrophy and failure

21 January 2018

1 reference

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

21 January 2018

1 reference

Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression

21 January 2018

1 reference

Evidence for a potent antiinflammatory effect of rosiglitazone

21 January 2018

1 reference

Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

21 January 2018

1 reference

Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes

21 January 2018

1 reference

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats

21 January 2018

1 reference

Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

21 January 2018

1 reference

Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.

21 January 2018

1 reference

Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

Transthoracic echocardiography in models of cardiac disease in the mouse.

21 January 2018

1 reference

Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat.

21 January 2018

1 reference

Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure

21 January 2018

1 reference

Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes

21 January 2018

1 reference

21 January 2018

1 reference

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

21 January 2018

1 reference

COX-2–Dependent Cardiac Failure in Gh/tTG Transgenic Mice

21 January 2018

1 reference

Troglitazone improves recovery of left ventricular function after regional ischemia in pigs

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1139/Y04-094

1 reference

11 December 2017

1 reference